Understanding the cellular and molecular basis of Chimeric Antigen Receptor T-cell therapy resistance
Understanding the cellular and molecular basis of Chimeric Antigen Receptor T-cell therapy resistance
了解嵌合抗原受体 T 细胞治疗耐药性的细胞和分子基础
批准号：
415410
负责人：
Chen Gregory M
金额：
$7.65万
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-10-01 至 2022-10-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Chimeric Antigen Receptor (CAR) T-cell therapy has been a major breakthrough in cancer therapy, and recent clinical trials indicate that it is a potentially life-saving option for the most common form of pediatric leukemia. These clinical trials highlight
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of the MetaGx computational platform for meta-analysis of cancer molecular subtypes
-
批准号：323987
-
项目类别：Studentship Programs
-
资助金额：$0.36万
-
财政年份：2015
-
负责人：Chen Gregory M
-
依托单位：
ICS IG 2014 Computational Biology Undergraduate Summer Student Health Research award - Pathway-level redundancy in cancer:a novel biomarker-discovery mechanism.
-
批准号：308999
-
项目类别：Studentship Programs
-
资助金额：$0.36万
-
财政年份：2014
-
负责人：Chen Gregory M
-
依托单位：
海外基金
